Report Highlights
Global sales of sterilization capital equipment and filtration consumables were $3.3 billion in 2010 and $3.8 billion in 2011. This market is expected to grow to nearly $5.3 billion by 2016, a compound annual growth rate (CAGR) of 7%.
Report Scope
This report organizes information from diverse sources into cohesive units that include overview, industry structure and technology sections, as well as regional sections that include the Americas (Canada, U.S., Mexico, Latin America and South America); EMRA; and Asia (Japan, China, Australia, New Zealand, India and other Asian countries).
The overview examines sterilization in general, the types of technology and regulatory influences. The industry structure section discusses the most active suppliers, with regard to relative market share, marketing strengths and forces that promote or hamper growth of technologies. The technology sections detail historical, current and projected (2011 through 2016) market values for filter, heat, chemical, radiation and emerging sterilization technologies.
Analyst Credentials
Peggy S. Lehr is the BCC Research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and a MS in Communication from the University of Denver. Ms. Lehr has worked within the publishing industry for both for-profit and not-for-profit organizations, and she specializes in marketing reports on the medical industry.
Report Highlights
- Overall sales in the U.S. market for sterilization equipment by type were nearly $1 billion in 2009 which is predicted to remain same in 2010. But by 2014, it is projected to increase to $1.2 billion, at 5 year compound annual growth rate (CAGR) of 3.2%.
- The largest segment filter sterilization market was nearly $572.3 million in 2009; which will remain same in 2010. This is projected to reach $652.6 million in 2014, for a 5-year CAGR of 3.3%.
- Sales in the heat sterilization market amounted to $499 million in 2009 and will remain same in 2010. This is projected to increase to $564 million in 2014, for a 5-year CAGR of 3.1%.
Report Highlights
- U.S. sales of capital equipment to the sterilization industry should reach $905.2 million in 2005 and $1.1 billion in 2010, rising at an average annual growth rate (AAGR) of 4.2%.
- The trends of value-added manufacturing and shorter hospital stays combined are holding capital equipment costs down and are leading to the use of more disposable than reusable items.
- This trend toward disposables spells success for filtration sterilization, where sales of sterilizing filters for liquids and gases will rise at an AAGR of 5.9% to $603.5 million in 2010.
- Heat sterilization technologies are the tried-and-true methods and purchases will rise to $505.3 million in 2010.
Report Highlights
-
Sterilization is an unrecognized element in a vast number of industries and manufacturing processes and there is an ongoing need for effective, safe, rapid and economic methods. Many products are regulated and monitored by the government for microbe control procedures and contamination levels and they cannot be sold unless they are sterilized. Other products benefit from sterilization, even if not mandated by law.
-
Sterilization methods are more than a century old. Processes for performing sterilization basically have remained unchanged, but the efficiency and performance of devices is changing and evolving, as are the materials that are being sterilized. Therefore, it is important to understand the various sterilization methods and their uses and to know the changes and directions sterilization technology is taking.
-
This report attempts to discuss all areas of the market and to identify significant suppliers, end market size and government and regulatory factors. Participating companies will be discussed with regard to relative market share, marketing strengths, participation in new segments and innovative marketing practices.
Related Reports
Antiseptics and Disinfectants
The global market for antiseptics and disinfectants in 2009 was at about $3.4 billion, and with a 12% increase, sales reached about $3.8 billion in 2010. The market is expected to rise at a compound annual growth rate (CAGR) of 11.1% and reach $7.1 billion by 2016.
Recent Reports
Technical Textiles: Global Markets
The global market for technical textiles is expected to grow from $213.8 billion in 2024 and is projected to reach $284.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Green Solvents: Technologies, Emerging Opportunities and Markets
The global market for green solvents reached $4.5 billion in 2023. The market is expected to grow from $4.9 billion in 2024 and forecast to reach $7.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.3% from 2024 through 2029.
Specialty Chemicals Integrated Across Multiple Vertical Applications: Global Markets
The global market for specialty chemicals is estimated to increase from $1.3 trillion in 2023 to reach $1.7 trillion by 2029, at a compound annual growth rate (CAGR) of 4.9% from 2024 through 2029.
Global Markets and Advanced Technologies for Paints and Coatings
The global market for paints and coatings was valued at $194.0 billion in 2023. The market is expected to grow from $203.8 billion in 2024 and should reach $263.2 billion by 2029, at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2029.
Global Markets for Adhesives & Sealants or Joining and Fastening
The global market for adhesives & sealants or joining and fastening is estimated to increase from $63.7 billion in 2023 to reach $81.6 billion by 2029, at a compound annual growth rate (CAGR) of 4.3% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More